Pacholczak-Madej, R.; Grela-Wojewoda, A.; Puskulluoglu, M.; Lompart, J.; Las-Jankowska, M.; Krawczak, K.; Wrona, E.; Zaręba, L.; Żubrowska, J.; Walocha, J.;
et al. Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience. Biomedicines 2022, 10, 2528.
https://doi.org/10.3390/biomedicines10102528
AMA Style
Pacholczak-Madej R, Grela-Wojewoda A, Puskulluoglu M, Lompart J, Las-Jankowska M, Krawczak K, Wrona E, Zaręba L, Żubrowska J, Walocha J,
et al. Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience. Biomedicines. 2022; 10(10):2528.
https://doi.org/10.3390/biomedicines10102528
Chicago/Turabian Style
Pacholczak-Madej, Renata, Aleksandra Grela-Wojewoda, Mirosława Puskulluoglu, Joanna Lompart, Manuela Las-Jankowska, Katarzyna Krawczak, Ewa Wrona, Lech Zaręba, Justyna Żubrowska, Jerzy Walocha,
and et al. 2022. "Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience" Biomedicines 10, no. 10: 2528.
https://doi.org/10.3390/biomedicines10102528
APA Style
Pacholczak-Madej, R., Grela-Wojewoda, A., Puskulluoglu, M., Lompart, J., Las-Jankowska, M., Krawczak, K., Wrona, E., Zaręba, L., Żubrowska, J., Walocha, J., Bazan-Socha, S., & Ziobro, M.
(2022). Early Effects of Nivolumab and Ipilimumab Combined Immunotherapy in the Treatment of Metastatic Melanoma in Poland: A Multicenter Experience. Biomedicines, 10(10), 2528.
https://doi.org/10.3390/biomedicines10102528
